CPMD

Cannapharmarx (CE) (CPMD)

Cannapharmarx Inc (CE)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:CPMD

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/02/22	21 : 55	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	USOTC:CPMD	Cannapharmarx Inc (CE)
2024/02/17	02 : 02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CPMD	Cannapharmarx Inc (CE)
2023/12/07	06 : 01	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CPMD	Cannapharmarx Inc (CE)
2023/11/18	06 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:CPMD	Cannapharmarx Inc (CE)
2023/11/15	05 : 01	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:CPMD	Cannapharmarx Inc (CE)
2023/11/14	03 : 51	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CPMD	Cannapharmarx Inc (CE)
2023/10/14	03 : 38	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CPMD	Cannapharmarx Inc (CE)
2023/10/13	23 : 20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:CPMD	Cannapharmarx Inc (CE)
2023/10/04	03 : 13	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:CPMD	Cannapharmarx Inc (CE)
2023/09/23	03 : 51	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:CPMD	Cannapharmarx Inc (CE)
2023/09/02	02 : 08	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:CPMD	Cannapharmarx Inc (CE)
2023/08/29	05 : 21	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:CPMD	Cannapharmarx Inc (CE)
2023/06/23	19 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CPMD	Cannapharmarx Inc (CE)
2023/03/30	23 : 44	AllPennyStocks.com	Cannabis Firm Signs Supply Agreement for up to $15 Million	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/12/22	00 : 08	InvestorsHub NewsWire	CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Annual Revenue over $30 Million	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/11/22	06 : 07	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/10/04	19 : 03	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/08/23	05 : 11	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/08/10	00 : 27	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/08/10	00 : 19	Edgar (US Regulatory)	Withdrawal of Registration Statement (rw)	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/08/09	06 : 04	Edgar (US Regulatory)	Securities Registration Statement (s-1/a)	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/08/02	22 : 09	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/05/23	20 : 42	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/05/16	20 : 32	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/04/15	23 : 19	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/04/01	05 : 37	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:CPMD	Cannapharmarx Inc (CE)
2022/02/17	06 : 02	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CPMD	Cannapharmarx Inc (CE)
2021/11/16	02 : 11	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CPMD	Cannapharmarx Inc (CE)
2021/08/17	04 : 13	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CPMD	Cannapharmarx Inc (CE)
2021/06/14	19 : 03	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:CPMD	Cannapharmarx Inc (CE)